What is not a recommended practice to control hepatitis C (hepatitis C virus, HCV) transmission in a dialysis clinic?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

All Listed Options ARE Recommended Practices for HCV Control in Dialysis

All three options (A, B, and C) are explicitly recommended infection control measures for preventing hepatitis C transmission in dialysis clinics, making "D. All of the above" the correct answer to this EXCEPT question.

Standard Infection Control Practices (Options A & B)

The KDIGO 2022 guidelines strongly recommend that hemodialysis facilities adhere to standard infection control procedures to prevent transmission of blood-borne pathogens 1. These specifically include:

  • Proper hand hygiene and glove changes, especially between patient contacts, before invasive procedures, and after contact with blood and potentially blood-contaminated surfaces 1
  • Thorough cleaning and disinfection of surfaces at the dialysis station, particularly high-touch surfaces 1
  • Proper injectable medication preparation following aseptic techniques 1
  • Adequate separation of clean supplies from contaminated materials 1

Multiple HCV outbreaks in hemodialysis centers have been traced to deficiencies in these infection control practices, including lapses in hand hygiene, glove use, injectable medication handling, and environmental surface disinfection 1. Regular observational audits of infection control procedures are recommended to ensure adherence 1.

Routine Serologic Testing and Surveillance (Option C)

Systematic HCV surveillance is a cornerstone of infection control in dialysis units 1:

  • Screen all patients upon initiation of in-center hemodialysis or transfer from another facility using immunoassay or nucleic acid testing (NAT) (Grade 1A recommendation) 1
  • Continue screening every 6 months for all in-center hemodialysis patients using immunoassay or NAT (Grade 1B recommendation) 1, 2
  • Hemodialysis centers must examine and track all HCV test results to identify new cases of infection (Grade 1B recommendation) 1

When a new HCV infection is identified, aggressive measures must be taken immediately 1:

  • Test all patients in the facility for HCV infection (Grade 1A) 1, 2
  • Increase testing frequency temporarily (monthly for 3 months, then at 6 months) 2
  • Conduct detailed review of infection control practices 1
  • Report seroconversion to public health authorities 1

What Is NOT Recommended

Notably, the guidelines explicitly recommend against certain practices that were historically used 1:

  • Do NOT use dedicated dialysis machines for HCV-infected patients (Grade 1D recommendation) 1
  • Do NOT isolate HCV-infected patients during hemodialysis sessions (Grade 2C recommendation) 1

These practices are not recommended because there is no evidence of HCV transmission through internal pathways of single-pass dialysis machines, and isolation does not improve outcomes when standard infection control procedures are properly followed 1.

Clinical Pitfall

The critical error in dialysis units is prioritizing patient isolation or dedicated machines over rigorous adherence to standard infection control practices 1. The KDIGO guidelines explicitly state that strategies to prevent HCV transmission should prioritize adherence to standard infection control practices and should not primarily rely upon treatment of HCV-infected patients 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hepatitis Screening and Surveillance in Dialysis Units

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the best approach to manage left hip pain in a 66-year-old male with a history of Hepatitis C, recent fall, and past trauma to the hip?
What is the best initial pain management option for a patient with a history of Hepatitis C Virus (HCV) infection presenting with severe abdominal pain?
Is hepatitis C an airborne disease?
What is the management approach for a patient in their 70s with a positive anti-Hepatitis C Virus (HCV) test, undetectable HCV Ribonucleic Acid (RNA), and elevated Serum Glutamic-Pyruvic Transaminase (SGPT) of 70?
What is the best birth control option for patients with hepatitis C (Hepatitis C virus)?
What is the best management approach for a patient with an aneurysm experiencing vasospasm?
What is the appropriate evaluation and management for a 14-year-old boy with left chest discomfort and body pain who is vitally stable?
Is intravenous (IV) Paracetamol (acetaminophen) 300mg effective for fever management in a hospitalized patient with potential liver disease and impaired renal function?
What is the most useful indicator of malnutrition in a patient with a history of self-starvation, episodes of vomiting, amenorrhea (absence of menstruation), hypotension (low blood pressure), and a significantly reduced Body Mass Index (BMI), presenting with fine hairs on arms and legs?
When should proton pump inhibitor (PPI) prophylaxis be started in critically ill patients?
Can an adult patient with hypertension and no significant kidney or liver dysfunction start with indapamide 1.5 mg daily?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.